Search

everythinglearnresearchcommunity

for

Search:↓

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Gene variation affects prostate issues and hair loss.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

The document covers various male health issues, their causes, treatments, and related conditions.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Different types of long-lasting stem cells are responsible for the growth and upkeep of the mammary gland.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Reporter characteristics affect detection of hair loss from cancer therapy.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.